Belatacept biosimilar (Alphamab) | Interleukin Related interleukin-related.com

Product Name :
Belatacept biosimilar (Alphamab)

Search keywords :
Belatacept

drugId :
null

Target Vo:
Cluster of differentiation 80

Target Vo Short Name :
CD80

Moa_Name:
Anti-CD80

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Suzhou Alphamab Co Ltd

Active Company_Name :
Jiangsu Alphamab Biopharmaceuticals Co Ltd

Active Indication_Name:
Arthritis, Rheumatoid

In Active Indication_Name:
Rejection of renal transplantation

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD38 Antibody
Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
TWIST Antibody: TWIST Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-TWIST polyclonal antibody. TWIST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.

Author: Interleukin Related

Related Posts